Cantel Medical Corp. announced earnings guidance for the year 2020. The company anticipates total fiscal year 2020 GAAP EPS of $2.41 to $2.46, and non-GAAP EPS of $2.78 to $2.83 with the acquisition of Hu-Friedy contributing approximately $0.25 on a GAAP and non-GAAP basis.